Ultime notizie per Intrepid Potash (NYSE:IPI) Azioni

Intrepid Potash

Intrepid Potash Inc produces and sells potash and potash byproducts in three main product segments: Potash, Trio, and Oilfield Solutions. The Potash segment produces and sells potash to the agricultural industry as a fertilizer input, the industrial market as a component of oil and gas drilling fluid, and the animal feed market as a nutrient supplement. The Trio segment produces and sells specialty fertilizer that consists of potassium, sulfate, and magnesium and is mined from langbeinite ore. The oilfield solutions segment offers water, high-speed potassium chloride mixing services, saltwater disposal services, and trucking services. The vast majority of revenue is generated in the United States, which is also the location of the firm's production facilities.

Intrepid Potash Inc

IPIC ENTERTAINMENT INC A by iPic Entertainment Inc.

IPic Entertainment Inc

IMPRO PRECISION IND LTD by IMPRO PRECISION INDUSTRIES LIMITED

Impro Precision Industries Ltd

INNOVATION PHARMACEUTICAL by Innovation Pharmaceuticals Inc.

Innovation Pharmaceuticals Inc

UBS analyst Joshua Spector maintains Intrepid Potash (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IPI#NYSE">IPI</a>) with a Sell and lowers the price target from $20 to $19.

News

Price Target

Analyst Ratings

UBS Maintains Sell on Intrepid Potash, Lowers Price Target to $19

<a href="https://www.bloomberg.com/news/articles/2025-03-31/trump-push-for-us-fertilizer-won-t-be-enough-to-replace-imports?embedded-checkout=true" title="https://www.bloomberg.com/news/articles/2025-03-31/trump-push-for-us-fertilizer-won-t-be-enough-to-replace-imports?embedded-checkout=true">https://www.bloomberg.com/news/articles/2025-03-31/trump-push-for-us-fertilizer-won-t-be-enough-to-replace-imports?embedded-checkout=true</a>

Politics

General

'Trump Push for US Fertilizer Won't Be Enough to Replace Imports' -Bloomberg Report

The United States has agreed to restore Russia's access to the world market for agricultural and fertilizer exports in the latest push for a full ceasefire agreement between <a href="https://www.benzinga.com/markets/25/03/44455074/oil-rises-as-us-and-russia-begin-talks-in-saudi-arabia-for-ukraine-ceasefire-black-sea-deal">Ukraine and Russia.</a>
The news is dragging down several fertilizer stocks and could see Russian oligarchs who faced previous sanctions fighting back for control of their companies.
What Happened: After Russia invaded Ukraine, sanctions were placed on Russian businesses and oligarchs, while the country <a href="https://www.benzinga.com/general/entertainment/22/03/26191880/how-russia-is-trying-to-replace-mcdonalds-and-peppa-pig">shut down American-owned businesses </a>like restaurants owned by McDonald's.
As part of the latest agreement, the U.S. and Russia have agreed to safe navigation and eliminating the use of force for commercial vessels in the Black Sea.
"The United States will help restore Russia's access to the world market for agricultural and fertilizer exports, lower maritime insurance costs, and&nbsp;enhance access to ports and payment systems for such transactions," a White House press briefing <a href="https://www.whitehouse.gov/briefings-statements/2025/03/outcomes-of-the-united-states-and-russia-expert-groups-on-the-black-sea/#:~:text=The%20United%20States%20will%20help,payment%20systems%20for%20such%20transactions.">said</a>.
Agricultural stocks like Intrepid Potash (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IPI#NYSE">IPI</a>), The Mosaic Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MOS#NYSE">MOS</a>) and Nutrien Ltd (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NTR#NYSE">NTR</a>) fell on the news Tuesday.
The agreement could see Russian agricultural companies and financial institutions involved in trade lifted from sanctions and rivals once again with other global agricultural companies.
Read Also: <a href="https://www.benzinga.com/news/global/25/03/44333033/trump-boasts-very-good-chance-of-russia-ukraine-ceasefire-but-zelenskyy-says-putin-broke-deals-25-tim">Trump Boasts &#8216;Very Good Chance&#8217; Of Russia-Ukraine Ceasefire, But Zelenskyy Says Putin Broke Deals 25 Times Before</a>
Why It's Important: Russia was one of the largest agricultural explorers before receiving sanctions after invading Ukraine and seeing its shipping routes under pressure to export to other countries.
Several Russian billionaires also received sanctions and, in some cases, stepped down from leadership roles and handed over stakes in their businesses to trusts or other parties.
With the latest news, time will tell if those Russian billionaires, who were mostly accused of being oligarchs and having close ties to Russian President Vladimir Putin, will be able to profit from the agriculture trade once again.
Andrey Melnichenko is the founder of EuroChem and listed as the 62nd richest person in the world by <a href="https://www.bloomberg.com/billionaires/">Bloomberg</a>. Melnichenko previously withdrew from the board of directors of EuroChem and Suek, a large coal company in the country. EuroChem is now controlled by a trust, which includes Melnichenko's wife.
Dmitry Mazepin founded UralChem Group and acquired several fertilizer producers. He was later sanctioned and lost a legal challenge to European Union sanctions in 2023. The EU said Mazepin was involved in a sector that provided revenue to the Russian Government in their ruling.
Mazepin was one of the last Russian businessmen to meet with Putin before Russia invaded Ukraine, according to a report from <a href="https://www.bloomberg.com/news/articles/2025-03-25/us-says-russia-ukraine-agree-ceasefire-in-black-sea">Bloomberg</a> citing the Kremlin website. Mazepin had to give up <a href="https://www.bloomberg.com/news/articles/2023-11-08/russian-fertilizer-tycoon-mazepin-loses-eu-sanctions-appeal?utm_source=chatgpt.com&amp;sref=TBDibEcD">control </a>of UralChem as part of sanctions.
The new agreement, which could push Russia's agriculture exports forward, could be good for the country and help the government raise money to support the war cause or to get the country back on its feet if a full ceasefire is reached.
Russian billionaires will likely fight for control of their companies, which could be an upcoming battle to watch.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/news/23/08/33849346/is-putin-starving-the-world-political-scientist-unravels-russias-strategy-in-ukraine">Is Putin &#8216;Starving The World&#8217;?: Political Scientist Unravels Russia&#8217;s Strategy In Ukraine</a></li>
</ul>
Photo: Shutterstock

Commodities

Global

U.S. Restores Russian Access To Fertilizer Exports: Could Sanctioned Oligarchs Benefit From Latest Push In Ceasefire Talks?

WIIM

Shares of fertilizer stocks are trading lower following a Bloomberg report suggesting the US is restoring Russian access to the market for fertilizer exports.

Macro Economic Events

Economics

U.S. Says It Is Restoring Russian Access To Market For Fertilizer Exports

Shares of fertilizer companies are trading higher after the U.S. Commerce Secretary, Howard Lutnick, said a tariff reprieve is likely to include all United States-Mexico-Canada Agreement covered products

UBS analyst Joshua Spector maintains Intrepid Potash (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IPI#NYSE">IPI</a>) with a Sell and lowers the price target from $21 to $20.

UBS Maintains Sell on Intrepid Potash, Lowers Price Target to $20

Intrepid Potash (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IPI#NYSE">IPI</a>) reported quarterly losses of $(0.11) per share which missed the analyst consensus estimate of $(0.04) by 175 percent. This is a 73.17 percent increase over losses of $(0.41) per share from the same period last year. The company reported quarterly sales of $55.80 million which beat the analyst consensus estimate of $50.35 million by 10.83 percent. This is a 1.52 percent decrease over sales of $56.66 million the same period last year.

Earnings

Earnings Beats

Earnings Misses

Intrepid Potash Q4 Adj $(0.11) Misses $(0.04) Estimate, Sales $55.80M Beat $50.35M Estimate

<h3>Companies Reporting Before The Bell</h3>
• Sphere Entertainment (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPHR#NYSE">SPHR</a>) is expected to report earnings for its second quarter. 
• TG Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TGTX#NASDAQ">TGTX</a>) is expected to report quarterly earnings at $0.08 per share on revenue of $99.36 million. 
• Plug Power (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLUG#NASDAQ">PLUG</a>) is estimated to report quarterly loss at $0.19 per share on revenue of $274.06 million. 
• Burford Capital (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BUR#NYSE">BUR</a>) is projected to report quarterly earnings at $0.59 per share on revenue of $216.00 million. 
• Avadel Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVDL#NASDAQ">AVDL</a>) is estimated to report quarterly loss at $0.04 per share on revenue of $52.70 million. 
• Mersana Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRSN#NASDAQ">MRSN</a>) is projected to report quarterly loss at $0.16 per share on revenue of $7.64 million. 
• AG Mortgage IT (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MITT#NYSE">MITT</a>) is estimated to report quarterly earnings at $0.20 per share on revenue of $17.01 million. 
• Syndax Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNDX#NASDAQ">SNDX</a>) is likely to report quarterly loss at $1.07 per share on revenue of $21.98 million. 
• Nomad Foods (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOMD#NYSE">NOMD</a>) is estimated to report quarterly earnings at $0.38 per share on revenue of $796.56 million. 
• Ocular Therapeutix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OCUL#NASDAQ">OCUL</a>) is projected to report quarterly loss at $0.22 per share on revenue of $16.89 million. 
• BioLife Solns (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLFS#NASDAQ">BLFS</a>) is expected to report quarterly loss at $0.03 per share on revenue of $22.77 million. 
• Surgery Partners (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SGRY#NASDAQ">SGRY</a>) is projected to report quarterly earnings at $0.49 per share on revenue of $828.01 million. 
• N-able (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NABL#NYSE">NABL</a>) is projected to report quarterly earnings at $0.08 per share on revenue of $113.77 million. 
• Ready Capital (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RC#NYSE">RC</a>) is estimated to report quarterly earnings at $0.26 per share on revenue of $55.44 million. 
• Hut 8 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HUT#NASDAQ">HUT</a>) is likely to report quarterly loss at $0.35 per share on revenue of $25.62 million. 
• Stereotaxis (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/STXS#AMEX">STXS</a>) is expected to report quarterly loss at $0.06 per share on revenue of $6.42 million. 
• Sunnova Energy Intl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOVA#NYSE">NOVA</a>) is likely to report quarterly loss at $0.67 per share on revenue of $234.99 million. 
• GEO Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GEO#NYSE">GEO</a>) is likely to report earnings for its fourth quarter. 
• Fortrea Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FTRE#NASDAQ">FTRE</a>) is likely to report quarterly earnings at $0.37 per share on revenue of $703.90 million. 
• California Resources (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRC#NYSE">CRC</a>) is expected to report quarterly earnings at $1.02 per share on revenue of $904.91 million. 
<h3>Companies Reporting After The Bell</h3>
• NuScale Power (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SMR#NYSE">SMR</a>) is estimated to report quarterly loss at $0.12 per share on revenue of $1.07 million. 
• B. Riley Financial (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RILY#NASDAQ">RILY</a>) is likely to report earnings for its fourth quarter. 
• ADMA Biologics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADMA#NASDAQ">ADMA</a>) is projected to report quarterly earnings at $0.16 per share on revenue of $113.40 million. 
• Ekso Bionics Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EKSO#NASDAQ">EKSO</a>) is expected to report quarterly loss at $0.08 per share on revenue of $5.30 million. 
• GigaCloud Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GCT#NASDAQ">GCT</a>) is projected to report quarterly earnings at $0.88 per share on revenue of $288.33 million. 
• Smart Sand (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SND#NASDAQ">SND</a>) is likely to report quarterly earnings at $0.09 per share on revenue of $65.90 million. 
• OFS Capital (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OFS#NASDAQ">OFS</a>) is estimated to report quarterly earnings at $0.23 per share on revenue of $10.30 million. 
• Fractyl Health (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GUTS#NASDAQ">GUTS</a>) is likely to report earnings for its fourth quarter. 
• Crawford &amp; Company Common Stock (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRD#NYSE">CRD</a>) is estimated to report quarterly earnings at $0.23 per share on revenue of $334.82 million. 
• MRC Global (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MRC#NYSE">MRC</a>) is projected to report quarterly earnings at $0.08 per share on revenue of $726.90 million. 
• W&amp;T Offshore (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WTI#NYSE">WTI</a>) is expected to report quarterly loss at $0.25 per share on revenue of $130.04 million. 
• Dave (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DAVE#NASDAQ">DAVE</a>) is estimated to report quarterly earnings at $1.08 per share on revenue of $95.23 million. 
• AST SpaceMobile (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASTS#NASDAQ">ASTS</a>) is expected to report quarterly loss at $0.15 per share on revenue of $1.88 million. 
• Ranger Energy Services (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RNGR#NYSE">RNGR</a>) is projected to report quarterly earnings at $0.18 per share on revenue of $142.60 million. 
• James River Gr Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JRVR#NASDAQ">JRVR</a>) is projected to report quarterly loss at $0.46 per share on revenue of $159.91 million. 
• Emergent BioSolutions (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EBS#NYSE">EBS</a>) is likely to report quarterly loss at $0.08 per share on revenue of $270.50 million. 
• Repay Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RPAY#NASDAQ">RPAY</a>) is expected to report quarterly earnings at $0.25 per share on revenue of $82.56 million. 
• Viant Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DSP#NASDAQ">DSP</a>) is expected to report quarterly earnings at $0.21 per share on revenue of $83.91 million. 
• GitLab (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GTLB#NASDAQ">GTLB</a>) is expected to report quarterly earnings at $0.23 per share on revenue of $206.48 million. 
• Crawford &amp; Company Common Stock (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRD#NYSE">CRD</a>) is projected to report quarterly earnings at $0.24 per share on revenue of $334.82 million. 
• Biodesix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BDSX#NASDAQ">BDSX</a>) is expected to report quarterly loss at $0.06 per share on revenue of $19.83 million. 
• Intrepid Potash (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IPI#NYSE">IPI</a>) is likely to report quarterly loss at $0.05 per share on revenue of $53.44 million. 
• Senseonics Holdings (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/SENS#AMEX">SENS</a>) is projected to report quarterly loss at $0.03 per share on revenue of $7.79 million. 
• Quantum-Si (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QSI#NASDAQ">QSI</a>) is estimated to report quarterly loss at $0.19 per share on revenue of $1.29 million. 
• NCR Atleos (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NATL#NYSE">NATL</a>) is estimated to report quarterly earnings at $1.02 per share on revenue of $1.10 billion. 
• Heidrick &amp; Struggles Intl (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HSII#NASDAQ">HSII</a>) is expected to report quarterly earnings at $0.63 per share on revenue of $263.33 million. 
• Concentra Group Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CON#NYSE">CON</a>) is likely to report quarterly earnings at $0.17 per share on revenue of $463.65 million. 
• ThredUp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TDUP#NASDAQ">TDUP</a>) is estimated to report quarterly loss at $0.13 per share on revenue of $70.65 million. 
• Okta (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OKTA#NASDAQ">OKTA</a>) is expected to report quarterly earnings at $0.74 per share on revenue of $669.10 million. 
• Kayne Anderson BDC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KBDC#NYSE">KBDC</a>) is estimated to report earnings for its fourth quarter. 
• BRC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRCC#NYSE">BRCC</a>) is expected to report quarterly loss at $0.05 per share on revenue of $106.20 million. 
• Whitestone REIT (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WSR#NYSE">WSR</a>) is expected to report quarterly earnings at $0.26 per share on revenue of $38.39 million. 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ADMA

ASTS

Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share

AVDL

BDSX

BLFS

BRCC

DAVE

EKSO

FTRE

GTLB

GUTS

HSII

JRVR

KBDC

MITT

MRSN

NABL

NATL

NOMD

NOVA

OCUL

OKTA

PLUG

RILY

RNGR

RPAY

SENS

SGRY

SNDX

SPHR

STXS

TDUP

TGTX

Earnings Scheduled For March 3, 2025

UBS analyst Joshua Spector maintains Intrepid Potash (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IPI#NYSE">IPI</a>) with a Sell and raises the price target from $19 to $21.

UBS Maintains Sell on Intrepid Potash, Raises Price Target to $21

Shares of fertilizer and potash stocks are trading higher on reports suggesting potash supplier Belaruskali cut production

U.S. stock futures were higher this morning, with the Dow futures gaining over 150 points on Tuesday.
Shares of Aehr Test Systems, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AEHR#NASDAQ">AEHR</a>) fell sharply in today's pre-market trading after the company reported worse-than-expected financial results for the <a href="https://www.benzinga.com/news/earnings/25/01/42962183/aehr-test-systems-stock-falls-after-q2-results-heres-why">second quarter on Monday.</a>
Aehr Test Systems reported quarterly earnings of 2 cents per share which missed the analyst consensus estimate of 4 cents. Quarterly revenue came in at $13.45 million which missed the analyst consensus estimate of $15.03 million and is a decrease from sales of $21.43 million from the same period last year.
Aehr Test Systems shares dipped 19.3% to $12.90 in pre-market trading
Here are some other stocks moving lower in pre-market trading.
<ul>
<li>FTAI Infrastructure Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FIP#NASDAQ">FIP</a>) shares tumbled 12.4% to $7.04 in pre-market trading.</li>
<li>Crown LNG Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGBS#NASDAQ">CGBS</a>) dipped 7.2% to $0.90 in pre-market trading.</li>
<li>Embecta Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EMBC#NASDAQ">EMBC</a>) fell 6% to $18.71 in pre-market trading.</li>
<li>Ardent Health Partners, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARDT#NYSE">ARDT</a>) fell 5.5% to $15.17 in pre-market trading.</li>
<li>Trump Media &amp; Technology Group Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DJT#NASDAQ">DJT</a>) fell 5.3% to $40.64 in pre-market trading after jumping over 21% on Monday.</li>
<li>Intrepid Potash, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IPI#NYSE">IPI</a>) fell 4.7% to $24.01 in pre-market trading after jumping more than 10% on Monday.</li>
<li>Bausch + Lomb Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BLCO#NYSE">BLCO</a>) fell 2.1% to $17.01 in pre-market trading.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/markets/25/01/42965686/top-2-industrials-stocks-that-may-fall-off-a-cliff-in-january">Top 2 Industrials Stocks That May Fall Off A Cliff In January</a></li>
</ul>

Pre-Market Outlook

Markets

Movers

Trading Ideas

AEHR

ARDT

BLCO

CGBS

EMBC

Aehr Test Systems Posts Weak Results, Joins Trump Media & Technology Group And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

Crutchfield brings more than 30 years of global mining and transformational leadership experience
Intrepid Potash, Inc. ("Intrepid," "we," "the Company," or "our") (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IPI#NYSE">IPI</a>) today announced the Board of Directors (the "Board") of Intrepid has appointed Kevin S. Crutchfield as Chief Executive Officer and Board director, effective immediately.

Management

Intrepid Potash Announces Appointment of Kevin S. Crutchfield As CEO, Effective Immediately

UBS analyst Joshua Spector maintains Intrepid Potash (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IPI#NYSE">IPI</a>) with a Sell and raises the price target from $18 to $19.

UBS Maintains Sell on Intrepid Potash, Raises Price Target to $19

Intrepid Potash shares are trading higher after the company reported better-than-expected Q3 financial results.

Intrepid Potash (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IPI#NYSE">IPI</a>) reported quarterly losses of $(0.02) per share which beat the analyst consensus estimate of $(0.13) by 84.62 percent. This is a 96.23 percent increase over losses of $(0.53) per share from the same period last year. The company reported quarterly sales of $57.55 million which beat the analyst consensus estimate of $44.19 million by 30.23 percent. This is a 5.66 percent increase over sales of $54.47 million the same period last year.

Intrepid Potash Q3 Adj $(0.02) Beats $(0.13) Estimate, Sales $57.55M Beat $44.19M Estimate

<a href="https://www.bloomberg.com/news/articles/2024-11-04/belarus-president-proposes-cutting-potash-production-with-russia">https://www.bloomberg.com/news/articles/2024-11-04/belarus-president-proposes-cutting-potash-production-with-russia</a>
Belarusian President Alexander Lukashenko proposed approaching Russian fertilizer producers to coordinate a 10% potash output cut to increase its price on the market, according to the state-run Belta news service.&nbsp;

Reported Earlier, 'Belarus President Proposes Cutting Potash Production With Russia' - Bloomberg

Bob Jornayvaz Steps Down as Chief Executive Officer and Director Following Extended Medical Leave of Absence
Intrepid Potash, Inc. ("Intrepid," "we," "the Company" or "our") (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IPI#NYSE">IPI</a>) today announced that Bob Jornayvaz has stepped down as Chief Executive Officer and as a Director of the Board following his extended medical leave of absence.
"We are thankful to Bob for his immeasurable contributions to the Company over the last two decades," said Barth Whitham, Chair of the Board. "Bob led numerous initiatives that strengthened our customer relationships, modernized our operations, and capitalized on our unique position as the only domestic producer of potash. He took great pride in the Company and its contributions to the domestic and global agriculture industry. Bob and his family remain in our thoughts, and we continue to wish him well in his recovery."
Intrepid's Chief Financial Officer, Matt Preston, will continue to serve as acting principal executive officer as the Board of Directors' search to identify a successor Chief Executive Officer remains ongoing. Mr. Whitham continued, "The Board's search for a CEO is well underway. In the interim, we are pleased to continue to have Matt and the rest of the management team lead the execution of Intrepid's strategic plan."

Intrepid Potash Announces Bob Jornayvaz Steps Down As Chief Executive Officer And Director Following Extended Medical Leave Of Absence; CFO, Matt Preston, Will Continue To Serve As Acting Principal Executive Officer As The Board Of Directors' Search To Identify A Successor Chief Executive Officer Remains Ongoing

Guidance

Intrepid Expects 2024 Potash Production To Be ~15% Higher Than 2023

Intrepid Potash (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IPI#NYSE">IPI</a>) reported quarterly sales of $62.055 million which beat the analyst consensus estimate of $50.950 million by 21.80 percent. This is a 23.42 percent decrease over sales of $81.035 million the same period last year.

Intrepid Potash Q2 Sales $62.055M Beat $50.950M Estimate

Press Releases

Intrepid Announces Date for Third Quarter 2024 Earnings Release

Intrepid Announces Third Quarter 2024 Results

Intrepid Publishes New Investor Presentation

American Potash Announces Rebrand to American Critical Minerals as Green River Project Positioned for Both Potash and Lithium Development and Announces Private Placement to Raise Up to $1 Million

Intrepid Potash Announces Appointment of Kevin S. Crutchfield as Chief Executive Officer

American Critical Minerals Provides Corporate Update

Intrepid Announces Appointment of Gonzalo Avendano to Board of Directors

Intrepid Announces Date for Fourth Quarter 2024 Earnings Release

Intrepid Announces Fourth Quarter and Full-Year 2024 Results

American Critical Minerals Applauds US Presidential Executive Order to Increase / Expedite Domestic Critical Mineral Extraction & Processing - Specifically including Potash

APCOD

APCOF

CSE:KCL

CSE:KCLI

American Vanguard Corporation Common Stock ($0.10 Par Value)

American Vanguard

Bioceres Crop Solutions Corp. - Ordinary Shares

Bioceres Crop Solutions

CF Industries Holdings, Inc. Common Stock

CF Industries Holdings

Corteva

Enlightify

Brazil Potash

Mosaic

N2OFF

Scotts Miracle-Gro Company (The) Common Stock

Scotts Miracle Gro

CVR Partners, LP Common Units representing Limited Partner Interests

CVR Partners

BMO Capital

Comments

Intrepid Potash

Notizie

Ultime notizie per Intrepid Potash (NYSE:IPI) Azioni

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO